Valuation: Edwards Lifesciences Corporation

Market Cap 5.36TCr 4.65TCr 4.36TCr 3.97TCr 7.48TCr 5,11900Cr 7.6TCr 51TCr 20TCr 2,56200Cr 20TCr 20TCr 8,54800Cr P/E 2026 *
36.8x
P/E 2027 * 28.2x
Enterprise Value 5TCr 4.33TCr 4.06TCr 3.7TCr 6.97TCr 4,77200Cr 7.08TCr 48TCr 19TCr 2,38900Cr 19TCr 18TCr 7,96900Cr EV / Sales 2026 *
7.4x
EV / Sales 2027 * 6.52x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.53%
1 week+3.63%
Current month+7.54%
1 month+0.84%
3 months+13.72%
6 months+22.00%
Current year+8.57%
1 week 88.6
Extreme 88.605
93.91
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
30/07/26 Sell

Executive/Senior Manager

-146 0.0000%
28/07/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+3.63%+19.16%+14.94% 5.36TCr
-1.18%+2.74%+22.92%+10.28% 22TCr
-0.92%+1.96%-2.51%-20.72% 14TCr
0.00%+7.37%-16.81%+31.53% 14TCr
+0.53%+4.85%-49.57%+0.70% 7.45TCr
+0.03%-0.51%-15.63%-17.27% 5.01TCr
+0.71%+5.62%+24.11%+17.88% 4.19TCr
-0.63%+3.46%+39.31%+43.40% 4.09TCr
+2.09%+4.95%-2.04%+2.77% 3.26TCr
+0.33%+1.57%-21.35%+25.37% 3.26TCr
Average -0.01%+3.90%-0.24%+10.89% 8.36TCr
Weighted average by Cap. -0.41%+4.42%+0.92%+8.61%

Financials

2026 *2027 *
Net sales 675.92Cr 585.89Cr 549.23Cr 500.79Cr 942.29Cr 65TCr 957.38Cr 6.47TCr 2.52TCr 32TCr 2.54TCr 2.48TCr 1,07700Cr 742.91Cr 643.96Cr 603.66Cr 550.42Cr 1.04TCr 71TCr 1.05TCr 7.11TCr 2.77TCr 35TCr 2.79TCr 2.73TCr 1,18400Cr
Net income 143.52Cr 124.4Cr 116.61Cr 106.33Cr 200.07Cr 14TCr 203.27Cr 1.37TCr 536.06Cr 6.86TCr 538.8Cr 527.13Cr 23TCr 189.67Cr 164.4Cr 154.12Cr 140.53Cr 264.41Cr 18TCr 268.65Cr 1.81TCr 708.45Cr 9.06TCr 712.07Cr 696.65Cr 30TCr
Net Debt -363.09Cr -314.72Cr -295.03Cr -269.01Cr -506.17Cr -35TCr -514.28Cr -3.47TCr -1.36TCr -17TCr -1.36TCr -1.33TCr -58TCr -519.47Cr -450.27Cr -422.1Cr -384.87Cr -724.17Cr -50TCr -735.77Cr -4.97TCr -1.94TCr -25TCr -1.95TCr -1.91TCr -83TCr
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
14/26/14 $92.56 -0.53% 27,92,779
12/26/12 $93.05 -0.65% 23,40,306
11/26/11 $93.66 +1.77% 31,38,661
10/26/10 $92.03 +2.57% 44,43,994
07/26/07 $89.72 +0.45% 24,42,024
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
93.05USD
Average target price
100.96USD
Spread / Average Target
+8.50%

Quarterly revenue - Rate of surprise